Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
17.20
-0.34 (-1.94%)
May 12, 2026, 3:00 PM CST
SHA:603896 Market Cap
SHA:603896 has a market cap or net worth of 3.41 billion as of May 12, 2026. Its market cap has decreased by -11.66% in one year.
Market Cap
3.41B
Enterprise Value
2.92B
Revenue
625.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.20
Market Cap Chart
Since May 10, 2017, SHA:603896's market cap has increased from 2.32B to 3.41B, an increase of 46.75%. That is a compound annual growth rate of 4.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 3.41B | -11.25% |
| Dec 31, 2025 | 3.84B | -8.63% |
| Dec 31, 2024 | 4.20B | -34.21% |
| Dec 29, 2023 | 6.39B | -18.28% |
| Dec 30, 2022 | 7.82B | -11.47% |
| Dec 31, 2021 | 8.83B | 75.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 10, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guanhao Biotech | 3.80B |
| Shanghai Shen Lian Biomedical | 3.62B |
| Guangdong VTR Bio-Tech | 3.54B |
| Novoprotein Scientific | 3.45B |
| Beijing Kawin Technology Share-Holding | 3.36B |
| Yantai Zhenghai Biotechnology | 3.27B |
| Hubei Goto Biopharm | 3.22B |
| Shenzhen Bioeasy Biotechnology | 3.20B |